Repurposing CRISPR to study aberrant AR signaling in models of castration-resistant prostate cancer

被引：0
|
作者：
Kounatidou, Evangelia E. [1 ]
Robson, Craig [1 ]
Gaughan, Luke [1 ]
机构：
[1] Newcastle Univ, Newcastle Upon Tyne, Tyne & Wear, England
来源：
CANCER RESEARCH | 2018年 / 78卷 / 13期
关键词：
D O I：
10.1158/1538-7445.AM2018-1796
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1796
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Spermine is a natural suppressor of AR signaling in castration-resistant prostate cancer
    Li, Xiao
    Li, Fei
    Ye, Fei
    Guo, Haotian
    Chen, Wentao
    Jin, Jia
    Wang, Yiran
    Dai, Pengfei
    Shi, Huili
    Tao, Hongru
    Dang, Wenzhen
    Ding, Yiluan
    Wang, Mingchen
    Jiang, Hualiang
    Chen, Kaixian
    Zhang, Naixia
    Gao, Dong
    Zhang, Yuanyuan
    Luo, Cheng
    [J]. CELL REPORTS, 2023, 42 (07):
  • [2] AR Copy Number and AR Signaling-directed Therapies in Castration-resistant Prostate Cancer
    Salvi, Samanta
    Conteduca, Vincenza
    Lolli, Cristian
    Testoni, Sara
    Casadio, Valentina
    Zaccheroni, Andrea
    Rossi, Lorena
    Burgio, Salvatore Luca
    Menna, Cecilia
    Schepisi, Giuseppe
    De Giorgi, Ugo
    [J]. CURRENT CANCER DRUG TARGETS, 2018, 18 (09) : 869 - 876
  • [3] Exploiting Dependence of Castration-Resistant Prostate Cancer on the Arginine Vasopressin Signaling Axis by Repurposing Vaptans
    Heidman, Laine M.
    Peinetti, Nahuel
    Copello, Valeria A.
    Burnstein, Kerry L.
    [J]. MOLECULAR CANCER RESEARCH, 2022, 20 (08) : 1295 - 1304
  • [4] Crosstalk Between AR and Wnt Signaling Promotes Castration-Resistant Prostate Cancer Growth
    Luo, Jun
    Wang, Dan
    Wan, Xuechao
    Xu, Yangguang
    Lu, Yali
    Kong, Zhe
    Li, Dujian
    Gu, Wei
    Wang, Chenji
    Li, Yao
    Ji, Chaoneng
    Gu, Shaohua
    Xu, Yaoting
    [J]. ONCOTARGETS AND THERAPY, 2020, 13 : 9257 - 9267
  • [5] Aberrant HER2 signaling is a therapeutic target in a subset of castration-resistant prostate cancer
    Russo, Joshua W.
    Gao, Xin
    Einstein, David J.
    Bubley, Glenn J.
    Balk, Steven P.
    [J]. CANCER RESEARCH, 2019, 79 (13)
  • [6] Androgen receptor (AR) aberrations in castration-resistant prostate cancer
    Waltering, Kati K.
    Urbanucci, Alfonso
    Visakorpi, Tapio
    [J]. MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2012, 360 (1-2) : 38 - 43
  • [7] ANDROGRAPHOLIDE TARGETS AR PATHWAY IN CASTRATION-RESISTANT PROSTATE CANCER
    Liu, Chengfei
    Sun, Meng
    Lou, Wei
    Chun, Jaeyeon
    Nadiminty, Nagalakshmi
    Evans, Christopher
    Gao, Allen
    [J]. JOURNAL OF UROLOGY, 2011, 185 (04): : E167 - E167
  • [8] Aberrant TGF-β Signaling Drives Castration-Resistant Prostate Cancer in a Male Mouse Model of Prostate Tumorigenesis
    Pu, Hong
    Begemann, Diane E.
    Kyprianou, Natasha
    [J]. ENDOCRINOLOGY, 2017, 158 (06) : 1612 - 1622
  • [9] DIETHYLSTILBESTROL IN CASTRATION-RESISTANT PROSTATE CANCER OESTROGENS IN CASTRATION-RESISTANT PROSTATE CANCER: BACK TO THE FUTURE?
    Sartor, Oliver
    [J]. BJU INTERNATIONAL, 2012, 110 (11B) : E736 - E736
  • [10] Efficacy of androgen signaling blockade in castration-resistant prostate cancer
    [J]. Nature Clinical Practice Urology, 2008, 5 (10): : 523 - 524
12345